- Janux is working with adviser after drawing takeover interest
- Shares quadruple this year
Drugmaker Janux Therapeutics Inc. is exploring options, including a potential sale, after receiving takeover interest from larger pharmaceutical companies, people with knowledge of the matter said.
The company, which develops tumor-activated immunotherapies to treat cancer, is working with a financial adviser to evaluate possibilities including a sale, according to the people, who asked not to be identified discussing confidential information.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.